Lq3 Pharmaceuticals

PharmaceuticalsSeries AMorrisville, USlq3pharma.com

Latest round

Series A

Last raised

Sep 2014

Total raised

$10M

Investors

2

About Lq3 Pharmaceuticals

Lq3 Pharmaceuticals is focused on developing innovative therapeutics to address unmet medical needs.Founded in 2013 and headquartered in Morrisville, US, Lq3 Pharmaceuticals specializes in creating targeted therapies.Lq3 Pharmaceuticals develops a range of pharmaceuticals aimed at treating specific medical conditions. This includes designing new therapeutics aimed at chronic diseases and targeting expansion into European and Asian markets by 2025.

Who invested in Lq3 Pharmaceuticals

2 investors across 1 round

See all investors in Lq3 Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 10, 2014

    Amount

    $10M

    Investors

    Locked

Questions about Lq3 Pharmaceuticals

Who invested in Lq3 Pharmaceuticals?

Lq3 Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Lq3 Pharmaceuticals raised?

Lq3 Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Lq3 Pharmaceuticals last raise money?

Lq3 Pharmaceuticals's most recent round on record is a Series A, in Sep 2014.

What does Lq3 Pharmaceuticals do?

Lq3 Pharmaceuticals is focused on developing innovative therapeutics to address unmet medical needs.

Where is Lq3 Pharmaceuticals headquartered?

Lq3 Pharmaceuticals is headquartered in Morrisville, US.

Which VCs invest in companies like Lq3 Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Lq3 Pharmaceuticals's stage. Their profiles are linked below.

Raising like Lq3 Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.